Introduction Introduction Introduction Introduction Introduction
Chronic otitis media (COM) is defined as permanent inflammatory disease in the middle ear and mastoid cavity with the presence of tympanic membrane perforation, discharge from the ear and often a proliferative process of the mucosal lining in the form of granulation tissue, polyp or cholesteatoma. It is one of the most important causes of acquired hearing loss. In recent years, more attention has been paid to molecular mechanisms of local inflammatory reactions in the pathogenesis of COM [1] . Typically, polymorphonuclear neutrophils, macrophages and their mediators take part in the chronic inflammatory process. Growing evidence points to the role of mast cells (MCs) not only in allergic but also in inflammatory reactions [2, 3] . This possible function of mast cells is associated with their specific localization closely to the external environment, their long life, and a wide spectrum of mediators stored in the granules of MCs [4] . It has been postulated that they are involved in chronic inflammatory diseases such as asthma, rheumatoid arthritis, coronary disease, bullous pemphigoid, interstitial cystitis, chronic bowel and intestinal diseases and multiple sclerosis [5, 6] .
Mastocytes participate in nonspecific immunological mechanisms in host defense against pathogens. They can phagocytize bacteria and release pro-inflammatory mediators due to contact with bacteria and their products [3, 4] . Mastocytes can also regulate the adaptive immunity to infection by modulation of dendritic cell and T-cell responses [3, 7, 8] and contribute to tissue remodeling in chronic inflammation [9] .
Mast cells are distributed abundantly in skin, lymphatic organs, mucosa of gastrointestinal and respiratory tracts. They are also present in middle ear mucosa in both animals and humans, especially in pars flaccida of tympanic membrane, in tubotympanum and pharyngeal ostium of Eustachian tube [10, 11] . In the middle ear, the highest density of MCs has been reported in well vascularized mucosa or mucosa covered by ciliated epithelium [11] . MCs are more abundant in the epithelium than in the subepithelial layer, as compared to adenoid [12] . The role of mast cells and their mediators, such as tryptase and histamine, has been assessed in pathology of the middle ear mainly in adenoid hypertrophy and otitis media with effusion (OME) [13] [14] [15] [16] [17] . Some studies have found increased number of MCs and higher levels of histamine in adenoid, which may indicate that mast cells are the source of inflammatory mediators for Eustachian tube and middle ear [13] [14] [15] . Increased counts of MCs and elevated tryptase levels, in effusion and in middle ear mucosa, have been demonstrated in allergic patients with OME [16, 17] . Clinical studies reporting high histamine levels in middle ear effusion in secretory otitis media [12, 18] and in acute otitis [19] , as well as experimental studies of guinea pigs in which histamine injection into the tympanic cavity had caused long-standing effusion [20] , also point to histamine participation in the pathomechanism of middle ear inflammation.
Mast cells have rarely been investigated in chronic otitis media and only a few studies about their participation in cholesteatoma are accessible. There are none dealing with the clinical features in COM. Albino et al. [21] found a 3-to 7-fold increased number of MCs in different types of cholesteatoma, more intense in a primary acquired one, and their localization was typical for intensive inflammatory process. The presence of tryptase and chymase has been reported in middle ear cholesteatoma, pointing to a participation of MCs proteases in the pathogenesis of the disease [22] . Sankovic et al. [23] found MCs in nearly all middle ear biopsies, although they were degranulated to a lesser extent in COM (37.8%) than in OME (81.8%).
Therefore, investigating the possible influence of mast cells on the outcome of COM, as an example of chronic inflammation, seems important. This is why the aim of our study was to assess the density of mast cells in granulation tissue in chronic otitis media and evaluate their participation in postoperative healing and recurrence of the disease, in concomitant bacterial infection, and in a type of COM.
Material and methods

Characteristics of study groups. Characteristics of study groups. Characteristics of study groups. Characteristics of study groups. Characteristics of study groups. Fifty-four patients (33 men, 21 women) with chronic otitis media, who had undergone surgical treatment, were enrolled into the study. The mean age was 46.4 ± 15.6 years, ranging from 19 to 77 years. All patients were assessed prior to surgery and operated on by the same surgeon (T.D.). Twenty one patients were subjected to radical mastoidectomy and 33 patients to radical modified mastoidectomy. Both operations are open (canal wall down) approaches, so the posterior canal wall between the tympanic cavity and the mastoid process is removed to improve drainage and aeration of middle ear cavities. The radical mastoidectomy is an extended type of operation in which all damaged tympano-ossicular elements (tympanic membrane, malleus, incus) are removed, in contrast to radical modified mastoidectomy, in which those which are still working are preserved during surgery and may serve for tympanoplasty [24] . The degrees of COM severity were nearly similar in this sample since the patients were subjected to types of operation, which are based on the same surgical strategy intended to avoid recurrence. Both of these operations are used in more advanced stage of COM.
The study group was divided according to clinical course of disease as follows: -group NR (no recurrence) -consisted of 25 patients (mean age 50.8 ± 17.8 years, 11 women) with a good clinical course, ear cavity healed well postoperatively and epithelialised after three months, there was no long--term discharge or recurrence of inflammation during five-year follow-up; -group R (recurrence) -consisted of 29 patients (mean age 42.7 ± 12.6 years, ten women) with poor postoperative healing and recurrence of disease during five--year follow-up. The patients were divided also according to coexistence and type of bacterial infection into three groups: -group B0 (n = 14 patients) -with no concomitant bacterial infection; -group B1 (n = 20 patients) -with Pseudomonas aeruginosa/Proteus sp./Staphyloccocus MRSA infection which constitute a separate group, as these bacteria are typical for COM but very difficult to eradicate. In group B1, Pseudomonas aeruginosa was the most frequent pathogen (17 patients, in one case coexistent with Staphylococcus aureus), Proteus sp. was noted in two patients and Staphylococcus aureus MRSA in one patient; -group B2 (n = 20 patients) -with bacterial infection different to that in group B1. In group B2, the following bacteria were found: Dyphteroides sp. issue samples. The density of mast cells was evaluated immunohistochemically by assessing tryptase activity in granulation samples removed during surgery from the tympanic cavity. Sections were prepared from formalin-fixed, paraffin-embedded material. In all specimens, the presence of granulation tissue was confirmed by a histopathologist (M.D.). In the pilot study, we identified mast cells in granulation tissue with toluidine blue staining and about half of them were degranulated.
Moreover, in all patients, the bacteriological examination to aerobes and fungi was made. The smears were obtained using sterile cotton swabs, then placed on agar plates for incubation, and identified. The tests determining phenotypes and mechanisms of resistance of isolated pathogens were also performed (MRSA, ESBL, HLAR, MLSB, MBL, VISA/VRSA).
Immunohistochemistry (IHC). Immunohistochemistry (IHC). Immunohistochemistry (IHC). Immunohistochemistry (IHC).
Immunohistochemistry (IHC). For immunohistochemical assay, 4 μm paraffin sections were mounted onto superfrost slides, deparaffinated in a sequence of xylene, dehydrated in a series of alcohols and rinsed twice in distilled water. Antigen was treated with 0.01 M citrate buffer, pH 6.0 (DAKO, Target Retrieval Solution) by heating in a microwave oven (parameters: 360 W -2 × 3 minutes, 180 W -2 × 5 minutes and 90 W -2 × 5 minutes). After cooling, sections were rinsed twice in 0.05 M buffer TRIS (TBS, DAKO), pH 7.6 for 5 minutes and incubated with 3% hydrogen peroxide (H 2 O 2 ) for 10 minutes in order to block endogenous peroxidase activity. Then monoclonal mouse anti-human Mast Cell Tryptase (Clone AA1, Dako Cytomation, Glostrup, Denmark, dilution 1:100) was applied. The sections were incubated for 1 hour with primary antibody diluted with DAKO Antibody Diluent with Background Reducing Components in a humid chamber at room temperature. Afterwards, sections were rinsed twice in TBS and visualisation system EnVision/HRP/DAB+ (DAKO Cytomation, Glostrup, Denmark) was used according to the manufacturer's instruction. After 30 minutes' incubation with horseradish peroxidase-conjugated secondary antibodies, the positive immunoreactivity was visualised using 3,3'--diaminobenzidine tetrachloride (DAB) as chromogen. After washing in distilled water, sections were counter-stained with hematoxylin and coverslipped. Negative controls were carried out by incubation in the absence of the primary antibody, and always yielded negative results.
Morphometry.
Morphometry. Morphometry. Morphometry. Morphometry. Staining of tryptase-positive mast cells was evaluated using a computer image analysis system consisting of a PC equipped with a Pentagram graphic tablet, an Indeo Fast card (frame grabber, true-color, real-time) produced by Indeo (Taiwan), and a color TV camera produced by Panasonic (Japan) coupled with a Carl Zeiss microscope (Germany). This system was programmed (MultiScan 8.08 software, produced by Computer Scanning Systems, Poland) to calculate the number of objects (automatic or semi-automatic function).
The density of tryptase-positive mast cells was evaluated using automatic function of MultiScan, with manual correction as needed. 
R R R R Results esults esults esults esults
In the whole group with chronic otitis media, the mean density of tryptase-positive mast cells was 102.1 and ranged from 2.0 to 137.2 per mm 2 of the section. The mean value of tryptase-positive MCs was significantly lower in the COM group with a good clinical course compared to the group with recurrence of disease (94.9 vs. 108.3 respectively, p = 0.006) ( Table 1 ). There were no significant differences in the mean density of tryptase-positive MCs between groups with and without concomitant bacterial infection (one-way ANO-VA p = 0.30); however, the Pseudomonas aeruginosa/ /Proteus sp/Staphyloccocus MRSA group had lower values than the B0 and B2 groups (95.6 vs. 109.2 vs. 103.7 respectively; post hoc tests: groups B0-B1: p = = 0.13, B0-B2: p = 0.54, B1-B2: p = 0.32). Similarly, there were no significant differences between the granulomatous and cholesteatomatous types of COM (p = 0.66).
The results of two-way ANOVA revealed that there was a significant main effect only for clinical course of COM (F = 7.97; df = 1; p = 0.007) and a tendency to main effect on presence and type of bacterial infection (F = 3.04; df = 2; p = 0.057), but the interaction effect between these factors was not significant (p = 0.98) (Figure 2 ). The two-way ANO-VA showed no interaction between clinical course and type of COM (p = 0.28) or between type of COM and bacterial infection (p = 0.36).
Discussion
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Our study assessed the participation of mast cells in chronic otitis media in relationship to some clinical features of the disease such as course, concomitant bacterial infection and type of COM. We used one of the human MCs' serine proteases, i.e. tryptase, which occurs in several types, including b-tryptase which is the main type stored in MCs' secretory granules. Tryptase occurs almost exclusively in mast cells and in trace amounts in basophiles, so it is considered as a reliable marker of MCs' activation [25] . Group N -good clinical course of chronic otitis media (COM); group R -recurrence of COM; group B0 -without bacterial infection; group B1 -with Pseudomonas aeruginosa/Proteus sp./Staphyloccocus MRSA infection; group B2 -with bacterial infection different to that of group B1; group G -granulomatous COM; group CH -cholestatomatous COM Figure 2 . Figure 2 . Figure 2 . Figure 2 . www.fhc.viamedica.pl
Our study found that patients with poorer postoperative healing and recurrence had significantly higher density of tryptase-positive mast cells than those with a good clinical course of chronic otitis media. This may suggest that mastocytes contribute to the maintenance of the inflammatory process. The role of mast cells in chronic inflammation is not fully understood. It has been reported that they are increased in inflammatory processes but there is contradictory evidence of their effect i.e. protective or deleterious [6] . This dual role of MCs in modulating inflammatory responses is realized by different mechanisms [26] . They release a wide range of mediators, such as preformed mediators, de novo synthesized mediators and cytokines, which can regulate inflammation [27] . Mastocytes are implicated in the recruitment and activation of neutrophils, monocytes/macrophages, and other inflammatory cells to sites of infection [6, 28] , in directing effector T cells and dendritic cells [29, 30] and in interplay with regulatory T cells [31] . They act also as epithelial and fibroblast mitogen in inflammatory tissue remodeling [32, 33] and in angiogenesis due to releasing heparin, histamine and angiogenic cytokines [5] . In middle ear structures, it has been shown that mast cells' degranulation causes the inflammatory reaction of tympanic membrane [34] ; however they may also contribute to healing of tympanic membrane perforations in acute otitis media [35] . It has also been demonstrated on the animal model of middle ear otitis that early inflammatory reaction to Haemophilus influenzae was less pronounced in W/Wv mice which did not exhibit proto-oncogene c-kit expression, so did not have mast cells, than in wild-type mice and W/Wv mice after reconstitution of MCs [36] .
Bacterial infection often causes an exacerbation in the clinical course and failure in treatment in chronic otitis media. This was seen in our study in the group with Pseudomonas aeruginosa/Proteus sp./Staphyloccocus MRSA in which recurrence was twice as frequent as in other groups. Bacterial toxins may activate MCs which, in response to infection, release many mediators causing an increase in vascular permeability and in the expression of adhesion molecules or act chemotactically directly on neutrophils and eosinophils, and also produce anti-microbial peptides like cathelicidins and defensins. Activation of human mast cells has been demonstrated for Staphylococcus aureus and Pseudomonas aeruginosa, which are the most common isolates from chronic otitis media [37] [38] [39] [40] . Chonmaitree et al. [19] reported that histamine levels were higher in bacteria-positive than bacteria-negative effusions in acute otitis media. Our study, however, failed to show any significant difference in density of MCs in relationship to bacterial infection or to demonstrate its protective antibacterial role in the chronic inflammatory process. Interestingly, the lowest mean density of mast cells both in N and R groups was observed in an infection that was more difficult to eradicate (Pseudomonas aeruginosa/ /Proteus sp./Staphyloccocus MRSA). It is plausible that the persistent inflammation caused by more resistant bacteria has exhausted MCs' proinflammatory abilities. The possible mechanisms observed in Pseudomonas aeruginosa infection may be due to mast cell apoptosis induced by exotoxin A [41] or modulation of MCs' activity and the release of cytokines by quorum sensing in biofilms [42] , which have also been shown in cholesteatoma [43] .
In the current study, we have hypothesized that mast cells are likely to show higher activity in cholesteatoma which is considered as a more aggressive type of COM because of the frequent destruction of adjacent bone and soft tissues. Berger et al. [44] have postulated that mast cells may play a role in bone resorption in COM as they were increased in tissues close to eroded ossicles. MCs may also release mediators like TNF-a, IL-b or N-acetylo-b-D-hexosoaminidase known to participate in bone destruction in cholesteatoma [45, 46] . However, in our study, the fact that there was no difference in the mean density of mast cells between both types of COM suggests that they did not contribute more to cholesteatoma. Although our immunohistochemical examination was performed in granulation tissue close to cholesteatoma and not in its perimatrix, it seems that participation of mast cells in otitis media is related to the chronicity of inflammatory process, rather than its type.
Conclusions
Conclusions Conclusions Conclusions Conclusions
The results of our study show that density of tryptasepositive mast cells in granulation tissue in chronic otitis media differs depending on clinical course, but not on bacterial infection or type of disease. It may suggest that mast cells contribute to the maintenance of inflammatory process, but not to antibacterial defense in chronic otitis media. 
